This company has been marked as potentially delisted and may not be actively trading. Athena Technology Acquisition (ATEK) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsHeadlinesOptions ChainShort InterestTrendsBuy This Stock ATEK vs. CRTX, OMCL, HSTM, MDRX, RRAC, AXAC, ENPC, HCMA, EVE, and DHHCShould you be buying Athena Technology Acquisition stock or one of its competitors? The main competitors of Athena Technology Acquisition include Cortexyme (CRTX), Omnicell (OMCL), HealthStream (HSTM), Veradigm (MDRX), Rigel Resource Acquisition (RRAC), AXIOS Sustainable Growth Acquisition (AXAC), Executive Network Partnering (ENPC), HCM Acquisition (HCMA), EVe Mobility Acquisition (EVE), and DiamondHead (DHHC). Athena Technology Acquisition vs. Its Competitors Cortexyme Omnicell HealthStream Veradigm Rigel Resource Acquisition AXIOS Sustainable Growth Acquisition Executive Network Partnering HCM Acquisition EVe Mobility Acquisition DiamondHead Cortexyme (NASDAQ:CRTX) and Athena Technology Acquisition (NYSE:ATEK) are both small-cap health care technology companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability, media sentiment and analyst recommendations. Which has higher valuation & earnings, CRTX or ATEK? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCortexymeN/AN/A-$89.94M-$2.97-0.57Athena Technology AcquisitionN/AN/AN/AN/AN/A Which has more risk and volatility, CRTX or ATEK? Cortexyme has a beta of 1.4, suggesting that its stock price is 40% more volatile than the S&P 500. Comparatively, Athena Technology Acquisition has a beta of 0.37, suggesting that its stock price is 63% less volatile than the S&P 500. Does the media prefer CRTX or ATEK? In the previous week, Athena Technology Acquisition had 1 more articles in the media than Cortexyme. MarketBeat recorded 1 mentions for Athena Technology Acquisition and 0 mentions for Cortexyme. Cortexyme's average media sentiment score of 0.67 beat Athena Technology Acquisition's score of 0.34 indicating that Cortexyme is being referred to more favorably in the media. Company Overall Sentiment Cortexyme Positive Athena Technology Acquisition Neutral Do institutionals & insiders hold more shares of CRTX or ATEK? 63.2% of Cortexyme shares are owned by institutional investors. Comparatively, 17.3% of Athena Technology Acquisition shares are owned by institutional investors. 27.9% of Cortexyme shares are owned by insiders. Comparatively, 88.4% of Athena Technology Acquisition shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Is CRTX or ATEK more profitable? Athena Technology Acquisition's return on equity of 0.00% beat Cortexyme's return on equity.Company Net Margins Return on Equity Return on Assets CortexymeN/A -70.96% -63.53% Athena Technology Acquisition N/A N/A N/A SummaryAthena Technology Acquisition beats Cortexyme on 4 of the 7 factors compared between the two stocks. Get Athena Technology Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for ATEK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ATEK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ATEK vs. The Competition Export to ExcelMetricAthena Technology AcquisitionHolding Offices Industry SectorNYSE ExchangeMarket Cap$101.50M$218.83M$2.08B$20.91BDividend YieldN/A3.17%13.66%3.59%P/E RatioN/A1.9712.2828.18Price / SalesN/A514.362,958,196.6456.00Price / CashN/A115.7757.5117.81Price / BookN/A8.253.104.57Net IncomeN/A-$10.81M-$456.46M$993.62M Athena Technology Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ATEKAthena Technology AcquisitionN/A$10.00flatN/AN/A$101.50MN/A0.002,021CRTXCortexymeN/A$1.68-2.3%N/A+208.0%$50.65MN/A-0.5755OMCLOmnicell2.9689 of 5 stars$31.69+0.7%$46.71+47.4%-25.5%$1.45B$1.11B63.383,670HSTMHealthStream4.5169 of 5 stars$26.49+2.1%$31.00+17.0%-5.0%$768.89M$291.65M39.541,093Positive NewsMDRXVeradigm3.0427 of 5 stars$4.60-2.1%$13.00+182.6%-52.1%$498.02M$1.53B0.008,000Positive NewsGap DownRRACRigel Resource AcquisitionN/A$11.50flatN/AN/A$368.81MN/A0.002,021AXACAXIOS Sustainable Growth AcquisitionN/A$10.43flatN/AN/A$228.66MN/A0.00N/AHigh Trading VolumeENPCExecutive Network PartneringN/A$5.33-1.8%N/A-20.3%$223.94MN/A0.001HCMAHCM AcquisitionN/A$5.92+5.0%N/A+4.3%$205.06MN/A0.00N/ANews CoverageGap UpEVEEVe Mobility AcquisitionN/A$11.27flat$5.00-55.6%N/A$175.77MN/A0.004DHHCDiamondHeadN/A$4.06-3.3%N/A-37.6%$175.11MN/A0.002Gap Up Related Companies and Tools Related Companies CRTX Alternatives OMCL Alternatives HSTM Alternatives MDRX Alternatives RRAC Alternatives AXAC Alternatives ENPC Alternatives HCMA Alternatives EVE Alternatives DHHC Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ATEK) was last updated on 8/18/2025 by MarketBeat.com Staff From Our PartnersBiotech Alert: With news on MPox, RSV, and more, this tiny firm could disrupt a $3B marketA small biotech is stepping into the spotlight with a first-in-class antiviral platform—and it could be one of...Smallcaps Daily | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | Sponsored"AI Upgrade" Coming Sept. 1stA new “AI Upgrade” is rolling out on September 1st—and tech leaders are calling it transformational. Softbank’...Behind the Markets | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Athena Technology Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Athena Technology Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access